MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-09-0010119
Plasmid Pharmaceutical Private Limited
Plasmid Pharmaceutical Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹11.79 Lakh
▲ 380% YoY
Net loss · FY 2024
₹1.2 Lakh
Net margin -10.2%
EBITDA · FY 2024
-₹1.17 Lakh
EBITDA margin -9.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Plasmid Pharmaceutical Private Limited
Data last updated:
Plasmid Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC316789. Its GSTIN is 07AAJCP1590L1Z0 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammad Sultan Khan and Faizul Haque Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 15 Basement West Nizamuddin Near Park New Delhi – 110013, Delhi, India – 110013.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.79 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.2 Lakh (net margin -10.2%) and EBITDA of -₹1.17 Lakh (EBITDA margin -9.9%). Revenue has declined at a compounded annual rate (CAGR) of 61% over three years and 3% over five years.
Plasmid Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0010119). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2017PTC316789
Registration Number 316789
Incorporation Date 26 April 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-09-0010119
Recognitions & Rankings of Plasmid Pharmaceutical
Contact details
Plasmid Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressF – 15 Basement West Nizamuddin Near Park New Delhi – 110013, Delhi, India – 110013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Plasmid Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Plasmid Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Plasmid Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Plasmid Pharmaceutical Private Limited, buy the company report.
Financials of Plasmid Pharmaceutical Private Limited
FY 2025 filings availablePlasmid Pharmaceutical Private Limited reported revenue of ₹11.79 Lakh (up 380% YoY) for FY 2024.
Revenue · FY 2024
₹11.79 Lakh ▲ 380%
Net loss · FY 2024
₹1.2 Lakh margin -10.2%
EBITDA · FY 2024
-₹1.17 Lakh margin -9.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 380%
3 years · compounded
▲ 61%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 239%
3 years · compounded
▼ 66%
5 years · compounded
▲ 8%
Revenue rose 380% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 239% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.9% | ||||
| Net Profit Margin | -10.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Plasmid Pharmaceutical Private Limited, buy the company report.
Board of directors of Plasmid Pharmaceutical Private Limited
Plasmid Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Sultan Khan | Director | 26 Apr 2017 | 9 Years 6 Months | Current |
| Faizul Haque Khan | Director | 19 Jun 2018 | 8 Years 4 Months | Current |
| Rehan Khan Also directs: Regulon Pharmaceutical Private Limited | Director | 26 Apr 2017 | 9 Years 6 Months | Current |
Peer comparison
Plasmid Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bhasin Cars Private Limited | ₹11.8 Lakh (FY 2024) | -91.0% | Delhi, India | |||
| Intellogic Software Private Limited | ₹11.8 Lakh (FY 2024) | -30.0% | Mangalore, Karnataka, India | |||
| Spicemate India Private Limited | ₹11.79 Lakh (FY 2022) | 55.0% | Vasai, Maharashtra, India | |||
| Saawariya Enterprise Private Limited | ₹11.79 Lakh (FY 2024) | 27.0% | Mumbai, Maharashtra, India | |||
| Elsing Paper Trading Private Limited | ₹11.79 Lakh (FY 2019) | -19.0% | Chennai, Tamil Nadu, India | |||
| Plasmid Pharmaceutical Private Limitedthis company | ₹11.79 Lakh (FY 2024) | -₹1.2 Lakh | -10.2% | 380.0% | New Delhi, Delhi, India | |
| Sattvika Hyper Pure Foods Private Limited | ₹11.79 Lakh (FY 2025) | 5.0% | Hyderabad, Telangana, India | |||
| Pentastack India Private Limited | ₹11.79 Lakh (FY 2025) | 192.0% | Pune, Maharashtra, India | |||
| Anandh Food Agencies Private Limited | ₹11.78 Lakh (FY 2020) | -100.0% | New Delhi, Delhi, India | |||
| Karakath Enterprises Private Limited | ₹11.78 Lakh (FY 2020) | -66.0% | Thrissur, Kerala, India | |||
| Naan Moons Entertainment Private Limited | ₹11.78 Lakh (FY 2024) | -75.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of Plasmid Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Plasmid Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Plasmid Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Plasmid Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCP1590L1Z0 | Delhi | Active | 01 Jun 2018 |
To see the full GST registrations and return filing status of Plasmid Pharmaceutical Private Limited, buy the company report.
Recent activity
Plasmid Pharmaceutical Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Mohd Ansari Farooq ceased to be Director on 26 Jul 2020.
AGM
Plasmid Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Plasmid Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Mohd Ansari Farooq ceased to be Director.
Appointed
Faizul Haque Khan was appointed as Director.
Appointed
Mohammad Sultan Khan was appointed as Director.
Appointed
Rehan Khan was appointed as Director.
Incorporation
26 Apr 2017
Plasmid Pharmaceutical Private Limited was registered on 26 Apr 2017 with Roc Delhi I & aged 9 years 6 months as per MCA records.
Frequently asked questions
Plasmid Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 April 2017 (9+ years old) and is registered under CIN U74999DL2017PTC316789.
Plasmid Pharmaceutical has 3 current directors:
- Mohammad Sultan Khan - Director
- Faizul Haque Khan - Director
- Rehan Khan - Director
The latest financial statements of Plasmid Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Plasmid Pharmaceutical is 07AAJCP1590L1Z0, registered in Delhi.
The CIN (Corporate Identification Number) of Plasmid Pharmaceutical is U74999DL2017PTC316789. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Plasmid Pharmaceutical was incorporated on 26 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Plasmid Pharmaceutical by revenue are Bhasin Cars Private Limited, Intellogic Software Private Limited, Spicemate India Private Limited, Saawariya Enterprise Private Limited, Elsing Paper Trading Private Limited and 5 more, all in the same principal business activity (retail trading).
Mohd Ansari Farooq ceased to be Director on 26 Jul 2020. Faizul Haque Khan was appointed as Director on 19 Jun 2018. Mohammad Sultan Khan was appointed as Director on 26 Apr 2017. Plasmid Pharmaceutical has 4 board changes on record in total.
Yes, Plasmid Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-09-0010119).
The registered office of Plasmid Pharmaceutical is at F – 15 Basement West Nizamuddin Near Park New Delhi – 110013, Delhi, India – 110013.
Plasmid Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.